Alleviation of paraquat-induced lung injury by pretreatment with bifunctional liposomes containing alpha-tocopherol and glutathione.

Reactive oxygen species are known to play a key role in the development of acute lung injury, and such injury can be alleviated by pretreating the lung with a suitable antioxidant preparation. In this study, we evaluated and compared the antioxidant efficacy of two liposomal preparations: liposomes containing only alpha-tocopherol versus bifunctional liposomes containing both alpha-tocopherol and glutathione (GSH). alpha-Tocopherol liposomes (2 mg alpha-tocopherol/animal) or liposomes containing both alpha-tocopherol and GSH (2 mg alpha-tocopherol and 10 mumol GSH/animal) were intratracheally instilled into the lungs of rats 30 min prior to a challenge with paraquat dichloride (30 mg/kg, i.p.); animals were killed 24 hr post-paraquat challenge. Lungs of paraquat-challenged animals were damaged extensively as evidenced by increases in lung weight, indicative of edema, and decreases in lung activities of angiotensin converting enzyme (ACE) and alkaline phosphatase (AKP), indicative of endothelial and alveolar type II epithelial cell injuries, respectively. While the pretreatment of rats with alpha-tocopherol liposomes or liposomes containing both alpha-tocopherol and GSH significantly attenuated paraquat-induced changes in lung ACE activity to more or less the same extent, the bifunctional liposomal preparation conferred additional protection to alveolar type II epithelial cells, as evidenced by a significantly higher pulmonary AKP activity. Our results also showed that both liposomal preparations failed to ameliorate paraquat-induced lung edema despite a significant protection of pulmonary endothelial cells, suggesting that paraquat-induced edema formation may be independent of endothelial cell damage. In conclusion, liposome-associated antioxidants can protect the lung against an oxidant challenge, and the extent of protection appears to be related to the characteristics of each antioxidant formulation.

[1]  B. Meyrick,et al.  Endotoxin and lung injury. , 1986, The American review of respiratory disease.

[2]  D. J. Reed.  Glutathione: toxicological implications. , 1990, Annual review of pharmacology and toxicology.

[3]  N. Mcintyre,et al.  Liposomes facilitate uptake of lipid-soluble vitamins after oral delivery to normal and bile-duct obstructed rats , 1989 .

[4]  J. Lazo,et al.  Bleomycin inhibition of angiotensin-converting enzyme activity from serum, lungs, and cultured pulmonary artery endothelial cells. , 2015, The American review of respiratory disease.

[5]  A. Meister,et al.  Transport of glutathione, as gamma-glutamylcysteinylglycyl ester, into liver and kidney. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Witschi.  Responses of the lung to toxic injury , 1990 .

[7]  D. Nadeau,et al.  Lung hydrolases in paraquat poisoning: early response of alkaline phosphatase. , 1987, Journal of toxicology and environmental health.

[8]  C. C. Reddy,et al.  Mechanism of Interaction of Vitamin E and Glutathione in the Protection against Membrane Lipid Peroxidation , 1989 .

[9]  S. Nojima,et al.  Transfer of Steroids and α-Tocopherol between Liposomal Membranes , 1980 .

[10]  L. Flohé,et al.  The fate of extracellular glutathione in the rat. , 1978, Biochimica et biophysica acta.

[11]  P. Shek,et al.  Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery. , 1994, Journal of drug targeting.

[12]  David Salsburg,et al.  Statistics for toxicologists , 1986 .

[13]  P. Smith,et al.  The pathology of the lung in paraquat poisoning , 1975, Journal of clinical pathology. Supplement.

[14]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[15]  L. Packer,et al.  Vitamin E in Health and Disease , 1997 .

[16]  A. Hayes.  Principles and methods of toxicology , 1982 .

[17]  P. Shek,et al.  Protective effect of liposome-associated alpha-tocopherol against paraquat-induced acute lung toxicity. , 1992, Biochemical pharmacology.

[18]  P. Shek,et al.  Pulmonary Uptake of Liposome‐associated α‐Tocopherol Following Intratracheal Instillation in Rats , 1993, The Journal of pharmacy and pharmacology.

[19]  J. Bus,et al.  Paraquat: model for oxidant-initiated toxicity. , 1984, Environmental health perspectives.

[20]  J. Crapo,et al.  Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. , 1984, The Journal of clinical investigation.

[21]  R. Garnier,et al.  Paraquat Poisoning , 1990, Drug safety.

[22]  R. Roberts,et al.  Tissue vitamin E levels in newborn rabbits after pharmacologic dosing. Influence of dose, dosage form, and route of administration. , 1985, Developmental pharmacology and therapeutics.

[23]  S. Kacew,et al.  Systematically applied chemicals that damage lung tissue. , 1985, Toxicology.

[24]  A. Tanswell,et al.  Liposome-mediated augmentation of catalase in alveolar type II cells protects against H2O2 injury. , 1987, Journal of applied physiology.

[25]  L. Machlin.  Vitamin E: A Comprehensive Treatise , 1980 .

[26]  D. Herndon,et al.  The challenge of burns , 1994, The Lancet.

[27]  M. Comporti.  Glutathione depleting agents and lipid peroxidation. , 1987, Chemistry and physics of lipids.

[28]  P. Shek,et al.  Distribution studies of liposome-encapsulated glutathione administered to the lung , 1990 .

[29]  J. Blennerhassett.  SHOCK LUNG AND DIFFUSE ALVEOLAR DAMAGE PATHOLOGICAL AND PATHOGENETIC CONSIDERATIONS , 1985, Pathology.

[30]  C. Dodia,et al.  Degradation and reutilization of alveolar phosphatidylcholine by rat lungs. , 1987, Journal of applied physiology.

[31]  P. Shek,et al.  Liposomal α-Tocopherol Alleviates the Progression of Paraquat-induced Lung Damage , 1995 .

[32]  L. Smith,et al.  Glutathione localization and distribution after intratracheal instillation. Implications for treatment. , 1992, The American review of respiratory disease.

[33]  D. J. Reed,et al.  Glutathione depletion and susceptibility. , 1984, Pharmacological reviews.

[34]  L. Packer,et al.  Vitamin E: Introduction to Biochemistry and Health Benefits , 1989, Annals of the New York Academy of Sciences.

[35]  I. Liener,et al.  Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase. , 2015, The American review of respiratory disease.

[36]  P. McCay,et al.  Evidence That Alpha‐Tocopherol Functions Cyclically to Quench Free Radicals in Hepatic Microsomes Requirement for Glutathione and a Heat‐Labile Factor , 1989, Annals of the New York Academy of Sciences.

[37]  P. Shek,et al.  Incorporation of α‐Tocopherol in Liposomes Promotes the Retention of Liposome‐encapsulated Glutathione in the Rat Lung , 1994, The Journal of pharmacy and pharmacology.

[38]  A. Boobis,et al.  Mechanisms of cell death. , 1989, Trends in pharmacological sciences.

[39]  M. Poznansky,et al.  Biological approaches to the controlled delivery of drugs: a critical review. , 1984, Pharmacological reviews.

[40]  A. Jobe,et al.  Clearance of phosphatidylcholine and cholesterol from liposomes, liposomes loaded with metaproterenol, and rabbit surfactant from adult rabbit lungs. , 1989, The American review of respiratory disease.

[41]  W. Pryor.  Free Radicals in Biology , 1976 .

[42]  A. Meister,et al.  Glutathione: interorgan translocation, turnover, and metabolism. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Tanswell,et al.  Liposome-mediated augmentation of antioxidant defenses in fetal rat pneumocytes. , 1990, The American journal of physiology.